About BioProcess360
BioProcess360 is a private equity firm founded in 2024. It is primarily based in Delray Beach, United States.
A lot of funds co-invest with BioProcess360, with names like M Ventures sharing a substantial percentage of its portfolio.
Key Metrics
BioProcess360's Portfolio
They have invested in a total of 2 companies. Their most recent investment was in Abselion (Series A round) on Oct 28, 2024. Here is the most recent investment by BioProcess360:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Oct 28, 2024 | Series A | 3955 | and 3 others | |
Aug 29, 2024 | Seed | 4877 |
Here is the portfolio snapshot of BioProcess360:
Investments by Year
The maximum number of investments were made in 2024
Co-investors of BioProcess360
Over the past 2 years, 5 investors have co-invested in BioProcess360's portfolio companies.
- Top Co-investors of BioProcess360: 5 investors entered a company along with BioProcess360. These include investors like M Ventures (1 company).
BioProcess360 News
•
Abselion Raises £6.6M in Series A FundingFinSMEs•Dec 09, 2024•Abselion, M Ventures, BioProcess360, Untitled Ventures and 2 others
•
Irubis secures pre-Series A financingMunich•Sep 04, 2024•IRUBIS, BioProcess360, Verve Ventures, Ventura Biomed
•
Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partnersmajunke.com•Aug 29, 2024•IRUBIS, BioProcess360, Verve Ventures
•
BioProcess360 Partners launch special life sciences investment fund to promote new tools and technologies for bioprocessingGlobeNewswire•Jul 18, 2024•BioProcess360, Ecolab
•
Manufacturing investment firm BioProcess360 launches with $100M for manufacturing tech companiesEndPoints News•Jul 17, 2024•BioProcess360
